CV logo

CAPSOVISION INC

CVNASDAQ
πŸ† #2517 by market capEarnings Aug 13 Β· PostUS Equity
$6.60β–Ό $0.08 (βˆ’1.20%)
πŸŒ™ After hours$6.60β–² 0.00%Regular close Β· extended-hours price shown
1hβ€”
24hβ–Ό 1.2%
7dβ€”
14dβ€”
30dβ€”
1yβ€”
🏦Market Cap
$330M
Small Cap
πŸ“ˆRevenue Growth (YoY)
β€”
πŸ“ŠGross Margin
51.7%
Healthy
πŸ’΅FCF Margin
β€”
βš–οΈP/S Ratio
24.6x
Expensive
Otter Score
61
Fair
No chart data available for CV.

Trading Snapshot

Day Range
$6.55 – $6.73
52-Week Range
$3.43 – $15.37
Volume
$1.90B
Avg Volume
$2.53B
Shares Outstanding
50.0M
Next Earnings
Oct 15, 2026

Fundamentals Snapshot

Annual Revenue
$14M
Last Q Revenue
$3M
P/E Ratio
β€”
P/S Ratio
24.6x
EPS (TTM)
$-0.58
Dividend Yield
β€”

Why Investors Own CV

  • βœ“High-growth profile β€” revenue up +41.7% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 57% gross margin and 8% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$14Mβ–² +37.0% YoY
Gross Margin (TTM)
56.6%β–² +2.0% YoY
Operating Income (TTM)
$2Mβ–² +37.0% YoY
Free Cash Flow (TTM)
$1Mβ–² +37.0% YoY

About CAPSOVISION INC

CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). It also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoView, a data access reading device for viewing capsule videos; CapsoAccess, a Capsule data access system; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services. The company serves gastrointestinal medical practices, clinics, and hospitals. It sells its products to distributor customers who resell products. The company was formerly known as Capso Vision Inc. and changed its name to CapsoVision, Inc. in May 2016. CapsoVision, Inc. was incorporated in 2005 and is headquartered in Saratoga, California.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Fair
61/100

Analyst Price Target

β“˜
Average Target
$8.70
β–² +31.8% Upside
High Target$10.75
Low Target$7.93
Based on 18 analysts

Latest News & Updates